These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 440896

  • 1. Long-term use of propranolol, ibuprofen, and spironolactone in the management of Bartter's syndrome.
    Cunningham RJ, Brouhard BH, Berger M, Petrusick T, Travis LB.
    Pediatrics; 1979 May; 63(5):754-6. PubMed ID: 440896
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
    Horký K, Schreiber V, Dvoráková J.
    Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacologic studies in Bartter's syndrome: opposite effects of treatment with antikaliuretic and antiprostaglandin drugs. Part I.
    Simatupang TA, Radó JP, Boer P, Geyskes GG, Vos J, Dorhout Mees EJ.
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):14-8. PubMed ID: 631965
    [Abstract] [Full Text] [Related]

  • 6. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
    Favre L, Glasson P, Flory ED, Dray F, Vallotton MB.
    Schweiz Med Wochenschr; 1979 Feb 03; 109(5):142-7. PubMed ID: 441720
    [Abstract] [Full Text] [Related]

  • 7. Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors.
    Littlewood JM, Lee MR, Meadow SR.
    Arch Dis Child; 1978 Jan 03; 53(1):43-8. PubMed ID: 415668
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bartter's syndrome--treatment with potassium, spironolactone and ACE-inhibitor.
    Clementsen P, Høegholm A, Hansen CL, Damkjaer M, Christensen P, Giese J.
    J Intern Med; 1989 Feb 03; 225(2):107-10. PubMed ID: 2646391
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of prostaglandins in Bartter's syndrome.
    Winterborn MH, Hewitt GJ, Mitchell MD.
    Int J Pediatr Nephrol; 1984 Mar 03; 5(1):31-8. PubMed ID: 6370882
    [Abstract] [Full Text] [Related]

  • 16. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T, Fujimaki M, Senba S, Saito I, Konishi K.
    J Lab Clin Med; 1984 Jun 03; 103(6):848-53. PubMed ID: 6373989
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Bartter's syndrome. Current prospects of nosographic classification and new therapeutic possibilities].
    Cordone G, Fasce L, Gianfranceschi P, Delucchi M, Iester A, Torcia R.
    Minerva Pediatr; 1978 Jul 15; 30(13):1097-104. PubMed ID: 672851
    [No Abstract] [Full Text] [Related]

  • 20. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
    Griffing GT, Aurecchia SA, Sindler BH, Melby JC.
    J Clin Pharmacol; 1982 Jul 15; 22(11-12):505-12. PubMed ID: 6761369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.